BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15281351)

  • 1. Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex).
    Stratakis CA; Matyakhina L; Courkoutsakis N; Patronas N; Voutetakis A; Stergiopoulos S; Bossis I; Carney JA
    Front Horm Res; 2004; 32():253-64. PubMed ID: 15281351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
    Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
    Stratakis CA
    Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary pathology in Carney complex patients.
    Stergiopoulos SG; Abu-Asab MS; Tsokos M; Stratakis CA
    Pituitary; 2004; 7(2):73-82. PubMed ID: 15761655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carney complex: pathology and molecular genetics.
    Boikos SA; Stratakis CA
    Neuroendocrinology; 2006; 83(3-4):189-99. PubMed ID: 17047382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
    Kirschner LS; Carney JA; Pack SD; Taymans SE; Giatzakis C; Cho YS; Cho-Chung YS; Stratakis CA
    Nat Genet; 2000 Sep; 26(1):89-92. PubMed ID: 10973256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Carney complex (myxomas, spotty pigmentation, endocrine overactivity, and schwannomas).
    Carney JA
    Dermatol Clin; 1995 Jan; 13(1):19-26. PubMed ID: 7712644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities.
    Boikos SA; Stratakis CA
    Pituitary; 2006; 9(3):203-9. PubMed ID: 17001464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PRKAR1A gene mutations in two patients with myxoma syndrome (Carney complex)].
    Skamrov AV; Feoktistova ES; Khaspekov GL; Kovalevskiĭ DA; Goriunova LE; Bibilashvili RSh; Vinnitskiĭ LI; Sheremet'eva GF; Nechaenko MA
    Kardiologiia; 2003; 43(7):77-82. PubMed ID: 12891303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: PRKAR1A: normal and abnormal functions.
    Bossis I; Stratakis CA
    Endocrinology; 2004 Dec; 145(12):5452-8. PubMed ID: 15331577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation.
    Courcoutsakis NA; Tatsi C; Patronas NJ; Lee CC; Prassopoulos PK; Stratakis CA
    Insights Imaging; 2013 Feb; 4(1):119-33. PubMed ID: 23315333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carney complex and lentiginosis.
    Horvath A; Stratakis CA
    Pigment Cell Melanoma Res; 2009 Oct; 22(5):580-7. PubMed ID: 19650827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male infertility as a component of Carney complex.
    Wieacker P; Stratakis CA; Horvath A; Klose S; Nickel I; Buhtz P; Muschke P
    Andrologia; 2007 Oct; 39(5):196-7. PubMed ID: 17714219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice.
    Veugelers M; Wilkes D; Burton K; McDermott DA; Song Y; Goldstein MM; La Perle K; Vaughan CJ; O'Hagan A; Bennett KR; Meyer BJ; Legius E; Karttunen M; Norio R; Kaariainen H; Lavyne M; Neau JP; Richter G; Kirali K; Farnsworth A; Stapleton K; Morelli P; Takanashi Y; Bamforth JS; Eitelberger F; Noszian I; Manfroi W; Powers J; Mochizuki Y; Imai T; Ko GT; Driscoll DA; Goldmuntz E; Edelberg JM; Collins A; Eccles D; Irvine AD; McKnight GS; Basson CT
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14222-7. PubMed ID: 15371594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A and its role in human neoplasia: the Carney complex paradigm.
    Bossis I; Voutetakis A; Bei T; Sandrini F; Griffin KJ; Stratakis CA
    Endocr Relat Cancer; 2004 Jun; 11(2):265-80. PubMed ID: 15163302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.
    Schernthaner-Reiter MH; Trivellin G; Stratakis CA
    Neuroendocrinology; 2016; 103(1):18-31. PubMed ID: 25592387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
    Kaltsas GA; Kola B; Borboli N; Morris DG; Gueorguiev M; Swords FM; Czirják S; Kirschner LS; Stratakis CA; Korbonits M; Grossman AB
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):443-8. PubMed ID: 12354125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carney complex.
    Espiard S; Bertherat J
    Front Horm Res; 2013; 41():50-62. PubMed ID: 23652670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.